Literature DB >> 26306497

Regulatory B cells mediate tolerance to apoptotic self in health: implications for disease.

Mohini Gray1, David Gray2.   

Abstract

B cells are able to regulate immune responses through the secretion of IL-10 and other inhibitory cytokines, though no transcription factor that can define 'regulatory B cells' as a separate lineage has yet been found. Instead it is likely that this function arises as a result of the immune context in which B cells find themselves and the stimuli they perceive. However, some B cells found within the B1a and the marginal zone subsets have a greater propensity to produce IL-10 than others. What are the natural stimuli for these cells to induce immune regulation? We discuss the role that the recognition of autoantigens exposed by apoptotic cells plays in stimulating IL-10 production in mouse and human studies. This mechanism involves the recognition and uptake of self-antigens by autoreactive BCRs, for delivery to endocytic compartments, where apoptosis-derived DNA binds to TLR9, driving IL-10 production. These 'natural' regulatory B cells represent a way of maintaining tolerance to self. We discuss how this may operate in inflammatory lesions where there is an excess of apoptotic leukocytes and how this impacts on our understanding of autoimmune disease. © The Japanese Society for Immunology. 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  B cell; apoptosis; autoimmunity; immune regulation; innate-like B cell

Mesh:

Substances:

Year:  2015        PMID: 26306497     DOI: 10.1093/intimm/dxv045

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

Review 1.  Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development.

Authors:  Laura I Salazar-Fontana; Dharmesh D Desai; Tarik A Khan; Renuka C Pillutla; Sandra Prior; Radha Ramakrishnan; Jennifer Schneider; Alexandra Joseph
Journal:  AAPS J       Date:  2017-01-12       Impact factor: 4.009

Review 2.  T cells and autoimmune kidney disease.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; David Klatzmann; George C Tsokos
Journal:  Nat Rev Nephrol       Date:  2017-03-13       Impact factor: 28.314

3.  Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

Authors:  Birgit Sawitzki; Paul N Harden; Petra Reinke; Aurélie Moreau; James A Hutchinson; David S Game; Qizhi Tang; Eva C Guinan; Manuela Battaglia; William J Burlingham; Ian S D Roberts; Mathias Streitz; Régis Josien; Carsten A Böger; Cristiano Scottà; James F Markmann; Joanna L Hester; Karsten Juerchott; Cecile Braudeau; Ben James; Laura Contreras-Ruiz; Jeroen B van der Net; Tobias Bergler; Rossana Caldara; William Petchey; Matthias Edinger; Nathalie Dupas; Michael Kapinsky; Ingrid Mutzbauer; Natalie M Otto; Robert Öllinger; Maria P Hernandez-Fuentes; Fadi Issa; Norbert Ahrens; Christoph Meyenberg; Sandra Karitzky; Ulrich Kunzendorf; Stuart J Knechtle; Josep Grinyó; Peter J Morris; Leslie Brent; Andrew Bushell; Laurence A Turka; Jeffrey A Bluestone; Robert I Lechler; Hans J Schlitt; Maria C Cuturi; Stephan Schlickeiser; Peter J Friend; Tewfik Miloud; Alexander Scheffold; Antonio Secchi; Kerry Crisalli; Sang-Mo Kang; Rachel Hilton; Bernhard Banas; Gilles Blancho; Hans-Dieter Volk; Giovanna Lombardi; Kathryn J Wood; Edward K Geissler
Journal:  Lancet       Date:  2020-05-23       Impact factor: 202.731

4.  Immune Tolerance to Apoptotic Self Is Mediated Primarily by Regulatory B1a Cells.

Authors:  Katherine Miles; Joanne Simpson; Sheila Brown; Graeme Cowan; David Gray; Mohini Gray
Journal:  Front Immunol       Date:  2018-01-19       Impact factor: 7.561

5.  Micro RNA-98 suppresses interleukin-10 in peripheral B cells in patient post-cardio transplantation.

Authors:  Jiangping Song; Wenjun Su; Xiao Chen; Qian Zhao; Ningning Zhang; Mao-Gang Li; Ping-Chang Yang; Liqing Wang
Journal:  Oncotarget       Date:  2017-04-25

Review 6.  Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application.

Authors:  Ling Bai; Wei Chen; Jingtao Chen; Wei Li; Lei Zhou; Chao Niu; Wei Han; Jiuwei Cui
Journal:  J Transl Med       Date:  2017-02-27       Impact factor: 5.531

7.  Antisense of survivin inhibits cervical cancer growth in mice.

Authors:  Hui Xu; Tingting Liang; Yongxia Yang; Yanlei Dong; Lin Zhu
Journal:  Arch Med Sci       Date:  2019-09-06       Impact factor: 3.318

Review 8.  Tolerance in Kidney Transplantation: What Is on the B Side?

Authors:  Laura Carreras-Planella; Francesc E Borràs; Marcella Franquesa
Journal:  Mediators Inflamm       Date:  2016-11-10       Impact factor: 4.711

9.  The soluble cytoplasmic tail of CD45 (ct-CD45) in human plasma contributes to keep T cells in a quiescent state.

Authors:  Alexander Puck; Stefan Hopf; Madhura Modak; Otto Majdic; Petra Cejka; Stephan Blüml; Klaus Schmetterer; Catharina Arnold-Schrauf; Jens G Gerwien; Klaus S Frederiksen; Elisabeth Thell; Judith Leitner; Peter Steinberger; Regina Aigner; Maria Seyerl-Jiresch; Gerhard J Zlabinger; Johannes Stöckl
Journal:  Eur J Immunol       Date:  2016-10-31       Impact factor: 5.532

10.  miR-21 silencing ameliorates experimental autoimmune encephalomyelitis by promoting the differentiation of IL-10-producing B cells.

Authors:  Hui Wang; Wenrong Xu; Qixiang Shao; Qing Ding
Journal:  Oncotarget       Date:  2017-10-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.